|
1
|
Voutsadakis IA: Epithelial-Mesenchymal
Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear
Receptors in Breast Cancer: A Review and in Silico Investigation. J
Clin Med. 5:52016. View Article : Google Scholar
|
|
2
|
Nie Y, Wu K, Yu J, Liang Q, Cai X, Shang
Y, Zhou J, Pan K, Sun L, Fang J, et al: A global burden of gastric
cancer: The major impact of China. Expert Rev Gastroenterol
Hepatol. 11:651–661. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Strong VE, Wu AW, Selby LV, Gonen M, Hsu
M, Song KY, Park CH, Coit DG, Ji JF and Brennan MF: Differences in
gastric cancer survival between the U.S. and China. J Surg Oncol.
112:31–37. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Feng RM, Zong YN, Cao SM and Xu RH:
Current cancer situation in China: Good or bad news from the 2018
Global Cancer Statistics? Cancer Commun (Lond). 39:222019.
View Article : Google Scholar
|
|
5
|
Monisha J, Roy NK, Bordoloi D, Kumar A,
Golla R, Kotoky J, Padmavathi G and Kunnumakkara AB: Nuclear Factor
Kappa B: A Potential Target to Persecute Head and Neck Cancer. Curr
Drug Targets. 18:232–253. 2017. View Article : Google Scholar
|
|
6
|
Fouani L, Kovacevic Z and Richardson DR:
Targeting Oncogenic Nuclear Factor Kappa B Signaling with
Redox-Active Agents for Cancer Treatment. Antioxid Redox Signal.
30:1096–1123. 2019. View Article : Google Scholar
|
|
7
|
Wang Y, Ni H, Li H, Deng H, Xu LS, Xu S,
Zhen Y, Shen H, Pan H and Yao M: Nuclear factor kappa B regulated
monocyte chemoat-tractant protein-1/chemokine CC motif receptor-2
expressing in spinal cord contributes to the maintenance of
cancer-induced bone pain in rats. Mol Pain.
14:17448069187886812018. View Article : Google Scholar
|
|
8
|
Fujimura T, Kambayashi Y, Furudate S,
Kakizaki A, Hidaka T and Aiba S: Possible mechanisms of the
crosstalk between Langerhans cells and regulatory T cells in
extramammary Paget disease by receptor activator of nuclear factor
kappa B (RANK) ligand/RANK pathways. Br J Dermatol. 176:387–394.
2017. View Article : Google Scholar
|
|
9
|
Cao HJ, Fang Y, Zhang X, Chen WJ, Zhou WP,
Wang H, Wang LB and Wu JM: Tumor metastasis and the reciprocal
regulation of heparanase gene expression by nuclear factor kappa B
in human gastric carcinoma tissue. World J Gastroenterol.
11:903–907. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tomonaga M, Hashimoto N, Tokunaga F,
Onishi M, Myoui A, Yoshikawa H and Iwai K: Activation of nuclear
factor-kappa B by linear ubiquitin chain assembly complex
contributes to lung metastasis of osteosarcoma cells. Int J Oncol.
40:409–417. 2012.
|
|
11
|
Gambhir S, Vyas D, Hollis M, Aekka A and
Vyas A: Nuclear factor kappa B role in inflammation associated
gastrointestinal malignancies. World J Gastroenterol. 21:3174–3183.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dolcet X, Llobet D, Pallares J and
Matias-Guiu X: NF-kB in development and progression of human
cancer. Virchows Arch. 446:475–482. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Helbig G, Christopherson KW II,
Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD, Broxmeyer HE and
Nakshatri H: NF-kappaB promotes breast cancer cell migration and
metastasis by inducing the expression of the chemokine receptor
CXCR4. J Biol Chem. 278:21631–21638. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cai Z, Tchou-Wong KM and Rom WN: NF-kappaB
in lung tumorigenesis. Cancers (Basel). 3:4258–4268. 2011.
View Article : Google Scholar
|
|
15
|
Tong HB, Zou CL, Qin SY, Meng J, Keller
ET, Zhang J and Lu Y: Prostate cancer tends to metastasize in the
bone-mimicking microenvironment via activating NF-κB signaling. J
Biomed Res. 32:343–353. 2018.PubMed/NCBI
|
|
16
|
Khurana N and Sikka SC: Targeting
Crosstalk between Nrf-2, NF-κB and Androgen Receptor Signaling in
Prostate Cancer. Cancers (Basel). 10:102018. View Article : Google Scholar
|
|
17
|
Sokolova O and Naumann M: NF-κB Signaling
in Gastric Cancer. Toxins (Basel). 9:92017. View Article : Google Scholar
|
|
18
|
Jiang XJ, Lin J, Cai QH, Zhao JF and Zhang
HJ: CDH17 alters MMP-2 expression via canonical NF-κB signalling in
human gastric cancer. Gene. 682:92–100. 2019. View Article : Google Scholar
|
|
19
|
Xu GY and Tang XJ: Troxerutin (TXN)
potentiated 5-Fluorouracil (5-Fu) treatment of human gastric cancer
through suppressing STAT3/NF-κB and Bcl-2 signaling pathways.
Biomed Pharmacother. 92:95–107. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang F, Yao Y, Wu J, Liu Q, Zhang J, Pu
X, Zhang Q and Xia L: Curcumin inhibits gastric cancer-derived
mesenchymal stem cells mediated angiogenesis by regulating
NF-κB/VEGF signaling. Am J Transl Res. 9:5538–5547. 2017.
|
|
21
|
Li YS, Wu LP, Li KH, Liu YP, Xiang R,
Zhang SB, Zhu LY and Zhang LY: Involvement of nuclear factor κB
(NF-κB) in the downregulation of cyclooxygenase-2 (COX-2) by
genistein in gastric cancer cells. J Int Med Res. 39:2141–2150.
2011. View Article : Google Scholar
|
|
22
|
Chen W, Wang X, Bai L, Liang X, Zhuang J
and Lin Y: Blockage of NF-kappaB by IKKbeta- or RelA-siRNA rather
than the NF-kappaB super-suppressor IkappaBalpha mutant potentiates
adriamycin-induced cytotoxicity in lung cancer cells. J Cell
Biochem. 105:554–561. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lun M, Zhang PL, Pellitteri PK, Law A,
Kennedy TL and Brown RE: Nuclear factor-kappaB pathway as a
therapeutic target in head and neck squamous cell carcinoma:
Pharmaceutical and molecular validation in human cell lines using
Velcade and siRNA/NF-kappaB. Ann Clin Lab Sci. 35:251–258.
2005.PubMed/NCBI
|
|
24
|
Ventura A and Jacks T: MicroRNAs and
cancer: Short RNAs go a long way. Cell. 136:586–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shukla GC, Singh J and Barik S: MicroRNAs:
Processing, Maturation, Target Recognition and Regulatory
Functions. Mol Cell Pharmacol. 3:83–92. 2011.PubMed/NCBI
|
|
26
|
Xu X, Yang X, Xing C, Zhang S and Cao J:
miRNA: The nemesis of gastric cancer (Review). Oncol Lett.
6:631–641. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Singh R, Ramasubramanian B, Kanji S,
Chakraborty AR, Haque SJ and Chakravarti A: Circulating microRNAs
in cancer: Hope or hype? Cancer Lett. 381:113–121. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen R, Alvero AB, Silasi DA, Kelly MG,
Fest S, Visintin I, Leiser A, Schwartz PE, Rutherford T and Mor G:
Regulation of IKKbeta by miR-199a affects NF-kappaB activity in
ovarian cancer cells. Oncogene. 27:4712–4723. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Taganov KD, Boldin MP, Chang KJ and
Baltimore D: NF-kappaB-dependent induction of microRNA miR-146, an
inhibitor targeted to signaling proteins of innate immune
responses. Proc Natl Acad Sci USA. 103:12481–12486. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee HM, Kim TS and Jo EK: MiR-146 and
miR-125 in the regulation of innate immunity and inflammation. BMB
Rep. 49:311–318. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Öztemur Islakoğlu Y, Noyan S and Gür
Dedeoğlu B: hsa-miR-301a- and SOX10-dependent miRNA-TF-mRNA
regulatory circuits in breast cancer. Turk J Biol. 42:103–112.
2018. View Article : Google Scholar
|
|
32
|
Xia X, Zhang K, Cen G, Jiang T, Cao J,
Huang K, Huang C, Zhao Q and Qiu Z: MicroRNA-301a-3p promotes
pancreatic cancer progression via negative regulation of SMAD4.
Oncotarget. 6:21046–21063. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou P, Jiang W, Wu L, Chang R, Wu K and
Wang Z: miR-301a is a candidate oncogene that targets the homeobox
gene Gax in human hepatocellular carcinoma. Dig Dis Sci.
57:1171–1180. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu Z, Li Y and Zhang G: Downregulation of
microRNA-301a inhibited proliferation, migration and invasion of
non-small cell lung cancer by directly targeting DLC1. Oncol Lett.
14:6017–6023. 2017.PubMed/NCBI
|
|
35
|
Wang M, Li C, Yu B, Su L, Li J, Ju J, Yu
Y, Gu Q, Zhu Z and Liu B: Overexpressed miR-301a promotes cell
proliferation and invasion by targeting RUNX3 in gastric cancer. J
Gastroenterol. 48:1023–1033. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu XD, He XJ, Tao HQ, Zhang W, Wang YY, Ye
ZY and Zhao ZS: Abnormal expression of miR-301a in gastric cancer
associated with progression and poor prognosis. J Surg Oncol.
108:197–202. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Coccia M, Rossi A, Riccio A, Trotta E and
Santoro MG: Human NF-κB repressing factor acts as a
stress-regulated switch for ribosomal RNA processing and nucleolar
homeostasis surveillance. Proc Natl Acad Sci USA. 114:pp.
1045–1050. 2017, View Article : Google Scholar
|
|
38
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The Eighth Edition AJCC Cancer Staging Manual:
Continuing to build a bridge from a population-based to a more
'personalized' approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Washington K: 7th edition of the AJCC
cancer staging manual: Stomach. Ann Surg Oncol. 7:3077–3079. 2010.
View Article : Google Scholar
|
|
40
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)). Method Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
41
|
Zaravinos A: The Regulatory Role of
MicroRNAs in EMT and Cancer. J Oncol. 2015:8658162015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Svoronos AA, Engelman DM and Slack FJ:
OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer.
Cancer Res. 76:3666–3670. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ma F, Zhang J, Zhong L, Wang L, Liu Y,
Wang Y, Peng L and Guo B: Upregulated microRNA-301a in breast
cancer promotes tumor metastasis by targeting PTEN and activating
Wnt/β-catenin signaling. Gene. 535:191–197. 2014. View Article : Google Scholar
|
|
44
|
Ni Z, Shang XF, Wang YF, Sun YJ and Fu DJ:
Upregulated microRNA-301a in osteosarcoma promotes tumor
progression by targeting CDC14A. Genet Mol Res. 15:152016.
View Article : Google Scholar
|
|
45
|
Liu L, Nie J, Chen L, Dong G, Du X, Wu X,
Tang Y and Han W: The oncogenic role of microRNA-130a/301a/454 in
human colorectal cancer via targeting Smad4 expression. PLoS One.
8:e555322013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bano N, Yadav M, Mohania D and Das BC: The
role of NF-κB and miRNA in oral cancer and cancer stem cells with
or without HPV16 infection. PLoS One. 13:e02055182018. View Article : Google Scholar
|
|
47
|
Alderton GK: Microrna: Micro loops in NF
κB signalling. Nat Rev Cancer. 11:62011. View Article : Google Scholar
|
|
48
|
Qiu W, He JH, Zuo H, Niu S, Li C, Zhang S,
Weng S, He J and Xu X: Identification, characterization, and
function analysis of the NF-κB repressing factor (NKRF) gene from
Litopenaeus vannamei. Dev Comp Immunol. 76:83–92. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zheng H, Takahashi H, Murai Y, Cui Z,
Nomoto K, Niwa H, Tsuneyama K and Takano Y: Expressions of MMP-2,
MMP-9 and VEGF are closely linked to growth, invasion, metastasis
and angiogenesis of gastric carcinoma. Anticancer Res. 26(5A): pp.
3579–3583. 2006, PubMed/NCBI
|
